LABORATORY PROCESSING / FOOD & BEVERAGE R&Dsales@labuhtsterilizer.com

News · Technical application ·

A Lab UHT Trial Sheet Needs More Than the Set Temperature

A laboratory UHT trial sheet should capture feed state, actual flow, measured thermal history, sampling and departures before anyone claims a validated lethality.

01 / EDITORIAL NOTE

Start with the sample and its feed state

A laboratory UHT trial sheet often begins with a temperature. That is understandable, because the setpoint is the number everyone watches during the run. It is also the least informative line on the page. Two runs at the same setpoint are not comparable if one used a strained base and the other carried pulp, or if one feed had been held overnight and the other was prepared immediately before startup.

The first page of the record should describe what actually entered the machine: the formulation name and revision, the preparation steps, a batch reference, the feed temperature, any measured solids or viscosity observation, and a short description of particles or pulp. If the feed was diluted, screened or blended during preparation, note the point at which that happened. These details explain why the pump, heat exchanger and holding assembly behaved as they did.

Feed state changes during a session as well. A formulation that is reheated, topped up or left to settle can present a different physical condition at the inlet. Record the preparation and holding time, and mark any substitution between runs. When material is limited, record the prepared mass or volume rather than only the planned batch size.

02 / EDITORIAL NOTE

Record flow and the measured thermal history

A temperature setpoint is an instruction to a controller. The product experiences a history that depends on the heat exchanger, the holding assembly, the actual flow and the physical properties of the feed. The record should therefore carry measured temperatures at defined positions: feed, heater outlet, holding-section inlet and outlet, and cooler outlet. Include the time of each reading and the instrument used.

Flow deserves the same treatment. Record the actual flow during each sampling window rather than the nominal capability of the configuration. In a laboratory unit, a small change in flow can alter the time spent in the holding section and the time available for heating and cooling. If the flow was adjusted during a run, mark the time and treat samples either side of the change as separate observations. Pressure readings at relevant points help explain pump behaviour, valve positions and any homogenizer setting.

When a homogenizer is part of the route, record its stage settings and the product temperature at the inlet. Pressure treatment and thermal treatment are separate equipment functions, but they interact physically in the product path. A trial sheet that lists only the thermal setpoint hides the condition of the material as it reached the homogenizing valve and as it left it.

If a holding-time calculation is used, state the equation, the assumed volume of the product path and the assumption of ideal plug flow. A calculated value is not a measurement. Residence time in real equipment can differ from a simple volume-divided-by-flow estimate, especially where connections, valves or a homogenizer change the path. The calculation is useful for planning, but it should not be presented as an observed product history.

03 / EDITORIAL NOTE

Define sampling before the run starts

Sampling decisions made during a run are difficult to reconstruct afterwards. Before startup, define the sample identifiers, containers, collection points, approximate collection windows and the tests planned for each sample. Separate startup and transition material from the steady-output window, and state what will be discarded. This is also the point to record how much material the run is expected to consume before any useful sample appears.

Record the collection boundary explicitly. Open research collection and filling inside a controlled cabinet have different preparation and handling requirements. Container preparation, filling sequence and closure handling belong in the record, not only in a separate laboratory procedure. If a cabinet is used, note its operating state and any qualification reference that applies on the day. The cabinet is a workspace; it does not make an upstream open process aseptic by itself.

Note the elapsed time and product condition at each collection. A label that names only a formulation cannot show whether the sample came from the beginning, middle or end of a run. When several formulations are processed in sequence, record the transition material between them.

04 / EDITORIAL NOTE

Log departures while they happen

Every trial has small departures: a temperature that settles slowly, a pump adjustment, a brief interruption, a feed top-up. These are normal, and they are also the events that make a sample difficult to interpret. The useful record notes the time, what changed, who acted and which samples were affected. Writing that down during the run is more reliable than reconstructing it from memory at the end of the day.

A deviations section is more valuable than a clean-looking summary written afterwards. If the run could not hold a planned condition, say so and describe the consequence for the sample set. Do not delete a run because it departed from plan; label it and retain the evidence. A record that shows an interrupted interval and identifies the affected samples is more useful than one that implies an uninterrupted steady state.

At the end of the run, record the cleaning and preparation steps that affect the next trial, including the rinse or cleaning sequence actually completed and any inspection finding. This links one run to the next and prevents a preparation difference from being mistaken for a product effect. It also gives the next operator a realistic starting point rather than an idealised procedure.

05 / EDITORIAL NOTE

Separate observations from validated lethality

A laboratory thermal trial can show how a formulation behaves in a defined equipment arrangement, and it can generate samples for further testing. It does not, by itself, establish a scheduled process for a commercial low-acid food. A nominal temperature does not demonstrate sterility, and a short laboratory run does not establish the performance of a production line.

In the United States, commercially processed, shelf-stable low-acid products in hermetically sealed containers may fall under the low-acid canned food framework, subject to the actual product classification and applicable exclusions. A qualified process authority should review that scope and establish the product- and package-specific scheduled process with records of the critical factors. Aseptic processing adds a sterile system boundary: the FDA inspection guide for aseptic processing and packaging directs attention to the process, equipment sterilization, residence-time evaluation and the records that demonstrate control. Those are regulatory and validation activities that sit outside a bench trial sheet.

The practical solution is language discipline. Report what was measured, over what interval, with which instrument and method. Describe sample handling and any departures. Then describe the next evidence needed rather than converting a laboratory observation into a treatment guarantee. A reader should be able to see the boundary between “we observed this in the trial” and “this process is validated for production”.

A trial sheet built this way is more useful than a page of setpoints. It supports a repeat run, a formulation comparison and an honest technical discussion with a process authority, a pilot plant or a production team.

Read the evidence

Sources and claim boundary

  1. Aseptic Processing and Packaging for the Food Industry — inspection guideU.S. Food and Drug Administration

    Used for the sterile system boundary, residence-time evaluation and record expectations described in this article.

  2. Low-Acid Foods Packaged in Hermetically Sealed Containers (LACF) Regulation and FSMA — guidance for industryU.S. Food and Drug Administration

    Used for the US low-acid product classification and the process-authority boundary. It is not a scheduled process for any product.

  3. LACF/AF — Precursor Questions and FlowU.S. Food and Drug Administration

    Used to delimit shelf-stable product scope and product-classification exclusions; it is not a product-specific process determination.

Source links open on the publisher's site. This article is editorial analysis: it does not establish a scheduled process, a validated lethality or a production-scale result for any product.

Your next laboratory project

Discuss equipment and configuration

Start with your product and the work you want to carry out.

Contact us